Successors and Assigns Clause Example from Business Contracts

This example Successors and Assigns clause appears in 33 contracts from 30 companies

Successors and Assigns. This Agreement shall inure to the benefit of and be binding upon the Company and Cowen and their respective successors and the affiliates, controlling persons, officers and directors referred to in Section 9 hereof. References to any of the parties contained in this Agreement shall be deemed to include the successors and permitted assigns of such party. Nothing in this Agreement, express or implied, is intended to confer upon any party other than the parties hereto or their respective successors... and permitted assigns any rights, remedies, obligations or liabilities under or by reason of this Agreement, except as expressly provided in this Agreement. Neither party may assign its rights or obligations under this Agreement without the prior written consent of the other party; provided, however, that Cowen may assign its rights and obligations hereunder to an affiliate of Cowen without obtaining the Company's consent. View More
Found in Avidity Biosciences, Inc. contract
HTG MOLECULAR DIAGNOSTICS, INC Contracts

Sales Agreement, dated as of March 13, 2019, by and between HTG Molecular Diagnostics, Inc. and Cowen and Company, LLC (Filed With SEC on March 13, 2019)

Krystal Biotech, Inc. Contracts

Sales Agreement, dated as of March 12, 2019, between Krystal Biotech, Inc. and Cowen and Company, LLC (Filed With SEC on March 13, 2019)

IMMUNOMEDICS INC Contracts

Sales Agreement, dated as of March 29, 2019, by and between Immunomedics, Inc. and Cowen and Company, LLC (Filed With SEC on March 29, 2019)

BOSTON OMAHA Corp Contracts

Sales Agreement dated August 13, 2019, by and between Boston Omaha Corporation and Cowen and Company, LLC (Filed With SEC on August 13, 2019)

Seres Therapeutics, Inc. Contracts

Sales Agreement, dated as of November 27, 2019, between Seres Therapeutics, Inc. and Cowen and Company, LLC (Filed With SEC on November 27, 2019)

Sales Agreement, dated as of March 18, 2020, between Seres Therapeutics, Inc. and Cowen and Company, LLC (Filed With SEC on March 18, 2020)

Intec Pharma Ltd. Contracts

Sales Agreement between Intec Pharma Ltd. and Cowen and Company, LLC dated March 1, 2019 (Filed With SEC on November 12, 2019)

DYNAVAX TECHNOLOGIES CORP Contracts

Sales Agreement, dated August 6, 2020, between the Company and Cowen and Company, LLC (Filed With SEC on August 6, 2020)

DYNAVAX TECHNOLOGIES CORPORATION Common Stock (par value $0.001 per share) SALES AGREEMENT (Filed With SEC on November 12, 2015)

Constellation Alpha Capital Corp. Contracts

Sales Agreement, dated as of November 10, 2020, by and between DermTech, Inc. and Cowen and Company, LLC (Filed With SEC on November 10, 2020)

Adverum Biotechnologies, Inc. Contracts

Common Stock Sales Agreement, dated December 17, 2020 (Filed With SEC on December 17, 2020)

Avidity Biosciences, Inc. Contracts

Sales Agreement, dated July 2, 2021, between Avidity Biosciences, Inc. and Cowen and Company, LLC (Filed With SEC on July 2, 2021)

Sales Agreement, dated November 8, 2022, between Avidity Biosciences, Inc. and Cowen and Company, LLC (Filed With SEC on November 8, 2022)

Annexon, Inc. Contracts

Sales Agreement, dated as of August 16, 2021, by and between Annexon Inc. and Cowen and Company, LLC (Filed With SEC on August 16, 2021)

Kezar Life Sciences, Inc. Contracts

Sales Agreement dated as of November 19, 2021, between the Company and Cowen and Company, LLC (Filed With SEC on November 19, 2021)

G1 Therapeutics, Inc. Contracts

Sales Agreement by and between the Registrant and Cowen and Company, LLC, dated as of February 23, 2022 (Filed With SEC on February 23, 2022)

Mersana Therapeutics, Inc. Contracts

Sales Agreement dated November 7, 2022 by and between the Company and Cowen and Company, LLC (Filed With SEC on November 7, 2022)

CHIASMA, INC Contracts

Sales Agreement, dated November 8, 2018, between Chiasma, Inc. and Cowen and Company, LLC (Filed With SEC on November 8, 2018)

ZAFGEN, INC. Contracts

Sales Agreement dated November 9, 2018 by and between Zafgen, Inc. and Cowen and Company, LLC (Filed With SEC on November 9, 2018)

VirnetX Holding Corp Contracts

Sales Agreement, dated August 31, 2018 by and between VirnetX Holding Corporation and Cowen and Company, LLC (Filed With SEC on August 31, 2018)

Myovant Sciences Ltd. Contracts

Sales Agreement, dated as of April 2, 2018, between Myovant Sciences Ltd. and Cowen and Company, LLC (Filed With SEC on April 3, 2018)

SANGAMO THERAPEUTICS, INC Contracts

SANGAMO BIOSCIENCES, INC. AT-THE-MARKET OFFERING PROGRAM SALES AGREEMENT (Filed With SEC on December 7, 2016)

Cascadian Therapeutics, Inc. Contracts

ONCOTHYREON INC. $50,000,000 SALESAGREEMENT (Filed With SEC on June 2, 2016)

Ultragenyx Pharmaceutical Inc. Contracts

ULTRAGENYX PHARMACEUTICAL INC. $150,000,000 SALESAGREEMENT (Filed With SEC on July 5, 2016)

MELINTA THERAPEUTICS, INC. Contracts

CEMPRA, INC. $150,000,000 SALESAGREEMENT (Filed With SEC on May 6, 2016)

Revance Therapeutics, Inc. Contracts

REVANCE THERAPEUTICS, INC. $75,000,000 COMMONSTOCK SALES AGREEMENT (Filed With SEC on March 7, 2016)

AMICUS THERAPEUTICS, INC. Contracts

AMICUS THERAPEUTICS, INC. $40,000,000 OF SHARES COMMON STOCK (PAR VALUE $0.01 PER SHARE) SALES AGREEMENT (Filed With SEC on March 4, 2014)

CYTORI THERAPEUTICS, INC. Contracts

CYTORI THERAPEUTICS, INC. $40,000,000 SALESAGREEMENT (Filed With SEC on May 12, 2014)

ReShape Lifesciences Inc. Contracts

ENTEROMEDICS INC. $25,000,000 SALESAGREEMENT (Filed With SEC on June 13, 2014)

AQUINOX PHARMACEUTICALS, INC Contracts

AQUINOX PHARMACEUTICALS, INC. $25,000,000 SALESAGREEMENT (Filed With SEC on April 1, 2015)

AMERICAN APPAREL, INC Contracts

AMERICAN APPAREL, INC. $10,000,000 AGGREGATE SALES PRICE OF COMMON STOCK SALES AGREEMENT (Filed With SEC on May 11, 2015)

TENAX THERAPEUTICS, INC. Contracts

Sales Agreement dated as of February 23, 2015, between Tenax Therapeutics, Inc. and Cowen and Company, LLC (Filed With SEC on July 14, 2015)

XOMA Corp Contracts

XOMA CORPORATION $75,000,000 SALESAGREEMENT (Filed With SEC on November 12, 2015)